Private equity outfit Kohlberg & Co. announced today that it has agreed to acquire a majority stake in pharma supply chain outsourcer PCI Pharma Services.
Abu Dhabi-based sovereign investor Mubadala Investment is also making a significant investment in Philadelphia-based PCI. Financial terms of the deal were not disclsoed.
Private markets investment manager Partners Group, previously PCI’s majority owner, will retain a meaningful minority stake.
PCI Pharma Services provides a broad range of integrated pharmaceutical supply chain solutions from the earliest stages of drug development through to commercial launch. It boasts global capabilities for drug development and manufacturing, clinical trials services and commercial packaging services — with 25 GMP facilities across six countries rougly 3,900 employees worldwide.
“Our teams at PCI have embarked on a purposeful journey over recent years to transform the company by executing a successf…